Larvol Delta - Chemomab-Announces-New-Patent-Awards-for-Its-FirstinClass-Agent-Nebokitug-that-is-Positioned-to-Potentially-Become-the-First-Approved-Drug-for-Primary-Sclerosing-Cholangitis

nebokitug intravenous (CM-101 intravenous) - ChemomAb

https://www.globenewswire.com/news-release/2025/06/03/3092706/0/en/Chemomab-Announces-New-Patent-Awards-for-Its-First-in-Class-Agent-Nebokitug-that-is-Positioned-to-Potentially-Become-the-First-Approved-Drug-for-Primary-Sclerosing-Cholangitis.html

Jun 3, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next